M&G (Lux) Better Health Solutions Fund EUR A Acc Fonds
|
WKN DE: A3DRAL / ISIN: LU2487616281
Anlageziel
The Fund has two aims: Financial objective: to provide a higher total return (capital growth and income) than that of the global equity market over any five-year period; and Impact objective: to invest in companies that deliver solutions to address better health and well-being. The Fund invests at least 80% of its Net Asset Value in the equity securities and equity related instruments of companies across any sector and market capitalisation that are domiciled, incorporated or listed in any developed market. The Fund has a concentrated portfolio of usually fewer than 40 companies.
Stammdaten
WKN | A3DRAL |
ISIN | LU2487616281 |
Fondsgesellschaft | M&G |
Kategorie | Branchen: Gesundheitswesen |
Währung | EUR |
Mindestanlage | 1 000,00 |
VL-fähig? | Nein |
Thesaurierend/Ausschüttend | Thesaurierend |
Fondsmanager |
Aktuelle Daten
Fondsnote | - |
Aktueller Rücknahmepreis | 10,86 |
Fondsvolumen | 16 055 842,36 |
Total Expense Ratio (TER) | 1,95 |
Gebühren
Verwaltungsgebühr | % |
Depotbankgebühr | % |
Rücknahmegebühr | % |
Ausgabeaufschlag | 4,00 % |
Basisdaten
Auflagedatum | 02.03.2023 |
Depotbank | State Street Bank International GmbH, Luxembourg Branch |
Zahlstelle | |
Domizil | Luxembourg |
Geschäftsjahr | 31.03.2024 |
Performancedaten
Veränderung Vortag | -0,01 |